702 participants
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-21
- Start Date:
- 2020-03-18
- Completion:
- 2023-05-26
Conditions
- Hidradenitis Suppurativa
Interventions
- DRUG